Hyundai Pharmaceutical Co., Ltd. (004310.KS)
KRW 3710.0
(-2.62%)
KRW 3710.0
(-2.62%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 225.81 KRW | 3914.36% |
| 2022 | -5.92 KRW | 94.8% |
| 2021 | -113.82 KRW | -242.44% |
| 2020 | 79.91 KRW | 79.61% |
| 2019 | 44.49 KRW | 158.54% |
| 2018 | -76.00 KRW | -10.14% |
| 2017 | -69.00 KRW | -224.28% |
| 2016 | 55.52 KRW | -16.18% |
| 2015 | 66.24 KRW | 7.94% |
| 2014 | 61.37 KRW | 5.0% |
| 2013 | 58.45 KRW | 128.99% |
| 2012 | -201.64 KRW | -592.89% |
| 2011 | 40.91 KRW | -66.13% |
| 2010 | 120.79 KRW | 82.35% |
| 2009 | 66.24 KRW | -48.09% |
| 2008 | 127.61 KRW | -62.85% |
| 2007 | 343.47 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 41.25 KRW | 254.38% |
| 2024 Q3 | -19.00 KRW | -146.06% |
| 2024 Q1 | 11.64 KRW | 351.16% |
| 2023 Q3 | 64.94 KRW | -43.53% |
| 2023 Q2 | 114.99 KRW | 89.16% |
| 2023 Q1 | 60.79 KRW | 127.5% |
| 2023 Q4 | 2.58 KRW | -96.03% |
| 2023 FY | - KRW | 3914.36% |
| 2022 Q3 | 87.00 KRW | 0.83% |
| 2022 FY | - KRW | 94.8% |
| 2022 Q4 | -221.08 KRW | -354.11% |
| 2022 Q2 | 86.28 KRW | 105.43% |
| 2022 Q1 | 42.00 KRW | 148.46% |
| 2021 Q2 | 16.00 KRW | 145.71% |
| 2021 Q3 | -8.24 KRW | -151.5% |
| 2021 Q1 | -35.00 KRW | -2077.4% |
| 2021 FY | - KRW | -242.44% |
| 2021 Q4 | -86.67 KRW | -951.82% |
| 2020 Q1 | 5.00 KRW | 380.9% |
| 2020 Q4 | 1.77 KRW | 105.21% |
| 2020 Q2 | 106.00 KRW | 2020.0% |
| 2020 Q3 | -34.00 KRW | -132.08% |
| 2020 FY | - KRW | 79.61% |
| 2019 Q3 | 8.13 KRW | -15.58% |
| 2019 FY | - KRW | 158.54% |
| 2019 Q2 | 9.63 KRW | -39.81% |
| 2019 Q4 | -1.78 KRW | -121.89% |
| 2019 Q1 | 16.00 KRW | 113.29% |
| 2018 Q1 | 15.00 KRW | 12.7% |
| 2018 Q2 | 17.00 KRW | 13.33% |
| 2018 Q3 | 11.00 KRW | -35.29% |
| 2018 FY | - KRW | -10.14% |
| 2018 Q4 | -120.39 KRW | -1194.45% |
| 2017 FY | - KRW | -224.28% |
| 2017 Q4 | 13.31 KRW | 13.86% |
| 2017 Q3 | 11.69 KRW | -41.05% |
| 2017 Q2 | 19.83 KRW | 35.73% |
| 2017 Q1 | 14.61 KRW | 94.8% |
| 2016 Q1 | 13.64 KRW | -43.82% |
| 2016 Q2 | 18.51 KRW | 35.7% |
| 2016 Q4 | 7.50 KRW | -23.0% |
| 2016 Q3 | 9.74 KRW | -47.38% |
| 2016 FY | - KRW | -16.18% |
| 2015 Q1 | 10.72 KRW | -42.77% |
| 2015 FY | - KRW | 7.94% |
| 2015 Q4 | 24.28 KRW | 149.28% |
| 2015 Q3 | 9.74 KRW | -56.52% |
| 2015 Q2 | 22.40 KRW | 108.96% |
| 2014 Q2 | 42.71 KRW | 99.3% |
| 2014 Q1 | 21.43 KRW | 355.12% |
| 2014 Q4 | 18.73 KRW | 28.2% |
| 2014 FY | - KRW | 5.0% |
| 2014 Q3 | 14.61 KRW | -65.79% |
| 2013 Q1 | 20.46 KRW | 201.59% |
| 2013 Q2 | 25.33 KRW | 23.8% |
| 2013 Q3 | 22.40 KRW | -11.57% |
| 2013 Q4 | -8.40 KRW | -137.5% |
| 2013 FY | - KRW | 128.99% |
| 2012 Q3 | -47.73 KRW | 66.21% |
| 2012 FY | - KRW | -592.89% |
| 2012 Q1 | 9.74 KRW | -50.08% |
| 2012 Q2 | -141.25 KRW | -1550.21% |
| 2012 Q4 | -20.14 KRW | 57.8% |
| 2011 FY | - KRW | -66.13% |
| 2011 Q1 | 60.40 KRW | 365.49% |
| 2011 Q2 | -10.72 KRW | -117.75% |
| 2011 Q3 | -27.28 KRW | -154.48% |
| 2011 Q4 | 19.51 KRW | 171.52% |
| 2010 Q3 | 116.89 KRW | 990.39% |
| 2010 Q1 | 17.53 KRW | -50.33% |
| 2010 Q4 | -22.75 KRW | -119.46% |
| 2010 FY | - KRW | 82.35% |
| 2010 Q2 | 10.72 KRW | -38.85% |
| 2009 FY | - KRW | -48.09% |
| 2009 Q4 | 35.29 KRW | 1108.56% |
| 2009 Q3 | 2.92 KRW | -62.52% |
| 2009 Q2 | 7.79 KRW | -46.68% |
| 2009 Q1 | 14.61 KRW | -54.95% |
| 2008 Q3 | -73.06 KRW | -188.24% |
| 2008 Q4 | 32.43 KRW | 144.39% |
| 2008 Q2 | 82.80 KRW | 7.59% |
| 2008 Q1 | 76.96 KRW | -15.84% |
| 2008 FY | - KRW | -62.85% |
| 2007 Q2 | 84.94 KRW | 18.09% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q3 | 95.80 KRW | 12.79% |
| 2007 Q4 | 91.44 KRW | -4.55% |
| 2007 Q1 | 71.93 KRW | 0.0% |